NDC 23155-473-44 Furosemide
Injection, Solution Intravenous
Package Information
What is NDC 23155-473-44?
The NDC Packaged Code 23155-473-44 is assigned to a package of 25 vial in 1 carton / 10 ml in 1 vial (23155-473-33) of Furosemide, a human prescription drug labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. The product's dosage form is injection, solution and is administered via intravenous form. The following table has all the important details about this NDC code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 23155-473-44 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
23155047344 | J1940 | Furosemide injection | 20 MG | 10 | 25 | 5 | 125 |
* Please review the disclaimer below.
Other Product Packages
The following packages are also available for Furosemide with product NDC 23155-473.
NDC Package Code | Package Description |
---|---|
23155-473-41 | 25 VIAL in 1 CARTON / 2 mL in 1 VIAL (23155-473-31) |
23155-473-42 | 25 VIAL in 1 CARTON / 4 mL in 1 VIAL (23155-473-32) |
23155-473-43 | 50 VIAL in 1 CARTON / 4 mL in 1 VIAL (23155-473-32) |
23155-473-45 | 50 VIAL in 1 CARTON / 10 mL in 1 VIAL (23155-473-33) |
* Please review the disclaimer below.